A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls

Condition:   Human Papilloma Virus
Interventions:   Drug: bivalent HPV vaccine;   Drug: nonavalent HPV vaccine
Sponsors:   London School of Hygiene and Tropical Medicine;   University of York;   Catalan Institute of Oncology;   National Cancer Institute at Frederick;   Karolinska Institutet;   Technische Universität Berlin;   Tanzanian National Institute for Medical Research;   University of Glasgow
Not yet recruiting - verified June 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/29W4dTW
via IFTTT